Samuel R Denmeade

Professor

1985 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Samuel R Denmeade is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Prodrugs Medicine & Life Sciences
Castration Medicine & Life Sciences
Androgens Medicine & Life Sciences
Thapsigargin Medicine & Life Sciences
Prostate Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2019

An IL-2 proaerolysin fusion toxin that selectively eliminates regulatory t cells to enhance antitumor immune response

Rogers, O., Yen, H., Solomon, A., Drake, C. & Denmeade, S. R., Jul 1 2019, In : Prostate. 79, 10, p. 1071-1078 8 p.

Research output: Contribution to journalArticle

Interleukin-2
Immunosuppressive Agents
Hemagglutinins
Neoplasms
Prostatic Neoplasms

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

Kapoor, R., Deek, M. P., McIntyre, R., Raman, N., Kummerlowe, M., Chen, I., Gaver, M., Wang, H., Denmeade, S., Lotan, T., Paller, C., Markowski, M., Carducci, M., Eisenberger, M., Beer, T. M., Song, D. Y., Deweese, T. L., Hearn, J. W., Greco, S., Deville, C. & 7 others, Desai, N. B., Heath, E. I., Liauw, S., Spratt, D. E., Hung, A. Y., Antonarakis, E. S. & Tran, P. T., Jun 13 2019, In : BMC cancer. 19, 1, 572.

Research output: Contribution to journalArticle

Open Access
Salvage Therapy
Prostatectomy
Double-Blind Method
Prostatic Neoplasms
Radiotherapy

A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma

Hahn, A. W., Drake, C., Denmeade, S. R., Zakharia, Y., Maughan, B. L., Kennedy, E., Link, C., Vahanian, N., Hammers, H. & Agarwal, N., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Immunotherapy
Kidney
Salvage Therapy
N-acetyllactosaminide alpha-1,3-galactosyltransferase
Open Access
Mesenchymal Stromal Cells
Prostatic Neoplasms
Bone Marrow
Safety
Neoplasms

A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer

Paller, C., Piana, D., Eshleman, J., Riel, S., Denmeade, S. R., Isaacsson Velho, P., Rowe, S., Pomper, M. G., Antonarakis, E., Luo, J. & Eisenberger, M., Jan 1 2019, In : Prostate. 79, 14, p. 1597-1603 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Circulating Neoplastic Cells
Therapeutics
Castration
Prostate-Specific Antigen